UNSPSC 51452600: Anthelmintic guanidines

Anthelmintics derived from a family of iminourea derivatives.

UNSPSC 51452600 Anthelmintic guanidines is a Class code that does not align with the state and local procurement activity tagged under it. The recent opportunities posted against this code—naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, medical and first aid supplies for fire rescue, and generic pharmaceuticals and OTC products—fall outside the anthelmintic guanidines scope. Anthelmintic guanidines are parasiticide pharmaceuticals with a narrow therapeutic application, yet the solicitations reflect broad pharmaceutical purchasing, emergency medical supplies, and health system procurement with no connection to anthelmintic treatment. The code shows little relevant recent activity for vendors in the anthelmintic guanidines specialty.

Recent posting volume and issuing-body diversity suggest misclassification rather than genuine demand under this code. Seminole County, Florida issued an IFB for naloxone and drug deactivation systems due July 26, 2023; the Texas Health and Human Services Commission issued an RFI on direct-to-manufacturer prescriptions due April 3, 2026; the City of Tampa issued an IFB for medical and first aid supplies (estimated $700,000) due March 13, 2026; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP for generic pharmaceuticals and OTC products due March 26, 2026. These solicitations span state agencies, counties, cities, and cooperative purchasing vehicles across Florida, Texas, Minnesota, and Oregon, but none target anthelmintic products. Firms pursuing anthelminmic guanidines should not rely on this code for market signals and should verify correct UNSPSC classification with state and local procurement offices before investing in pursuit strategy.